Elite Pharmaceuticals Inc. (ELTP) Insider Trading

Last 12 months

Insiders bought $35k on the open market and sold nothing.

Net open-market

+$35k

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Oct 2026

Oct 9, 2026

Get an email when ELTP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 9	Barry H Dash Director	Bought	100,000	$0.26	$26k	3.1%	Form 4
Aug 19	Barry H Dash Director	Bought	30,000	$0.29	$9k	0.9%	Form 4
Oct 2, 2025	Douglas Plassche EVP Operations	SoldNo plan	800,000	$0.62	$496k	19%	Form 4
Aug 22, 2025	Elite Pharmaceuticals INC EVP Operations	SoldNo plan	500,000	$0.52	$260k	10%	Form 4
Jul 10, 2025	Kirko Kirkov Chief Commercial Officer	Bought	16,366	$0.59	$10k	New	Form 4
Jul 8, 2025	Douglas Plassche EVP Operations	SoldNo plan	200,000	$0.58	$116k	8.0%	Form 4
Oct 24, 2024	Douglas Plassche SVP of Operations	SoldNo plan	333,932	$0.51	$170k	100%	Form 4

Oct 9
Barry H Dash
Director · bought 100,000 at $0.26
$26k
3.1% of stake
Aug 19
Barry H Dash
Director · bought 30,000 at $0.29
$9k
0.9% of stake
Oct 2, 2025No plan
Douglas Plassche
EVP Operations · sold 800,000 at $0.62
$496k
19% of stake
Aug 22, 2025No plan
Elite Pharmaceuticals INC
EVP Operations · sold 500,000 at $0.52
$260k
10% of stake
Jul 10, 2025
Kirko Kirkov
Chief Commercial Officer · bought 16,366 at $0.59
$10k
New position
Jul 8, 2025No plan
Douglas Plassche
EVP Operations · sold 200,000 at $0.58
$116k
8.0% of stake
Oct 24, 2024No plan
Douglas Plassche
SVP of Operations · sold 333,932 at $0.51
$170k
100% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ELTP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Pharmaceutical Preparations

ZVRAZevra Therapeutics, Inc.

KPTIKaryopharm Therapeutics Inc.

HRTXHeron Therapeutics Inc.

DAWNDay One Biopharmaceuticals, Inc.

RCUSArcus Biosciences Inc.

SPRYArs Pharmaceuticals Inc

GYREGyre Therapeutics Inc.

NUVBNuvation Bio Inc.

Spot a number that looks wrong? Check it in ELTP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ELTP

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.